effects [qlco]
Hormone replacement therapy [topp]
Plasma viscosity [lbpr]
Doppler [diap]
variations [qlco]
postmenopausal [tmco]
non smokers [fndg]
Heavy [qlco]
smokers [fndg]
objectives [inpr]
Evaluate [ftcn]
effects [qlco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Biological [bmod]
cardiovascular risk factor [dsyn]
Thromboxane B2 [eico]
Plasma viscosity [lbpr]
investigated [ftcn]
Doppler [diap]
Flow [npop]
Modification [ftcn]
Uterine [bpoc]
internal carotid [bpoc]
Eye [bpoc]
Bladder Wall [bpoc]
Arteries [bpoc]
Evaluated [ftcn]
Examined [fndg]
Parameters [fndg]
postmenopausal [tmco]
Women [popg]
non smokers [fndg]
Heavy [qlco]
smokers [fndg]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
Age-Years [tmco]
Mean deviation [clna]
Standard [qlco]
Study [mnob]
divided [ftcn]
Group [idcn]
Group I [inpr]
N NOS [aapp, imft]
normal control [qlco]
Group [idcn]
Ii [aapp]
N NOS [aapp, imft]
Heavy [qlco]
smokers [fndg]
Patients [podg]
treated [topp]
Continuous [idcn]
Estradiol [horm, phsu, strd]
Transdermal [ftcn]
Supplementation [topp]
Courses [tmco]
medroxyprogesterone acetate [horm, phsu, strd]
2 Months [tmco]
Study [mnob]
baseline [bodm]
months [tmco]
Estrogen [horm, phsu, strd]
Phase [tmco]
Cycle [tmco]
Hormone [horm]
Substitution [idcn]
months [tmco]
therapy [ftcn]
Plasma viscosity [lbpr]
Decreased [qnco]
months [tmco]
therapy [ftcn]
non smokers [fndg]
Heavy [qlco]
smokers [fndg]
Plasma [bdsu]
Thromboxane [bacs, eico]
baseline [bodm]
reduction [npop]
Group I [inpr]
Group [idcn]
Ii [aapp]
Doppler [diap]
Assessment [hlca]
Pulsatility index [clna]
Uterine [bpoc]
internal carotid [bpoc]
Eye [bpoc]
Bladder Wall [bpoc]
Arteries [bpoc]
reduction [npop]
Vascular impedance [orgf]
End [spco]
treatment [ftcn]
Group [idcn]
treatment [ftcn]
Heavy [qlco]
smokers [fndg]
Conclusions [idcn]
cigarette smoking [hops]
Represent [acty]
cardiovascular risk factor [dsyn]
Modified [ftcn]
Administration [ocac]
Transdermal [ftcn]
Hormone replacement therapy [topp]
